An All Night Spermicide?

For a money-losing young pharmaceutical company, Columbia Laboratories has been attracting some smart-money pros of late, including Stanley Knowlton of Knowlton Bros., whose firm took a 5.3% stake, and Bill Hopke of Dominion Capital (and an outside director of Columbia Labs), who owns close to 5%.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.